U.S. health insurers say Gilead hepatitis C drug too costly | (Reuters) - The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines, accusing drugmakers of taking advantage of the insurance system by pricing products at unsustainable levels. | | | | India to double drug inspectors to boost oversight | MUMBAI (Reuters) - India will spend 30 billion rupees ($511 million) and double the number of drug inspectors in the next three years to meet global manufacturing standards, the country's health regulator said on Wednesday. | | | | Texting improves link between sick teens and doctors | NEW YORK (Reuters Health) - Adolescents with chronic diseases who were allowed to text their doctors were better equipped to manage their own healthcare and more likely to request help at the first sign of problems, a new study found. | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment